Latest Content

In the phase 3 SHARE trial, salvage radiation given in 26 sessions kept cancer in check as well as 33 sessions did, with more late bowel side effects.

Rasonque offers a new targeted treatment option for metastatic pancreatic cancer. Dr. Kristin Higgins explains the approval, trial results and side effects.

I have worked alongside Lori Ranallo for 23 years and watched her guide patients with breast cancer from diagnosis through survivorship and beyond.

GYN oncologist Dr. Ami Vaidya, explains what gynecologic cancers are, why awareness matters and how patients can learn to recognize symptoms.

Nona Baker discusses the misdiagnoses that came first, why families need support and what has changed since.

A friend’s 28-year cancer journey taught one woman how to find hope, stay optimistic and live fully after her own incurable cancer diagnosis.

FDA approves Rasonque, a first-in-class targeted therapy for metastatic pancreatic cancer, offering a new treatment option for eligible patients.

A testicular cancer survivor shares his story of early detection, embracing failure, and redefining success through hard-won life lessons.

Dolly Parton has died at 80 following a brief battle with cancer. Learn what is known about her diagnosis, legacy and resources for those affected.

An incoming medical oncologist at the University of Cincinnati on how patient values shape treatment, and what precision medicine can now target.

Breast oncologist Dr. Zunairah Shah explains how breast cancer research is improving treatment, biomarker testing and options such as antibody-drug conjugates.

FDA approves Ziihera combinations for first-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma, expanding treatment options.

Dr. Matthew Carr explains how CAR T-cell therapy works, who may be eligible and how doctors decide when to treat or monitor cancer.